DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A

Overview of attention for article published in PLOS ONE, October 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 153 Dimensions

Readers on

mendeley: 83 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Method for synthesizing Alisporivir

Application CN-103145811-A

China

NEW TREATMENTS OF HEPATITIS C VIRUS INFECTION

Application WO-2012072655-A1

World Intellectual Property Organisation (WIPO)

COMPOSITIONS AND METHODS FOR PREDICTING HCV SUSCEPTIBILITY TO ANTIVIRAL AGENTS

Application WO-2012039964-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.